vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $62.1M, roughly 1.9× Cytek Biosciences, Inc.). Resolute Holdings Management, Inc. runs the higher net margin — -1.5% vs -70.9%, a 69.5% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $-1.8M).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

CTKB vs RHLD — Head-to-Head

Bigger by revenue
RHLD
RHLD
1.9× larger
RHLD
$117.7M
$62.1M
CTKB
Higher net margin
RHLD
RHLD
69.5% more per $
RHLD
-1.5%
-70.9%
CTKB
More free cash flow
RHLD
RHLD
$191.0M more FCF
RHLD
$189.2M
$-1.8M
CTKB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
RHLD
RHLD
Revenue
$62.1M
$117.7M
Net Profit
$-44.1M
$-1.7M
Gross Margin
52.9%
55.7%
Operating Margin
-9.0%
30.2%
Net Margin
-70.9%
-1.5%
Revenue YoY
8.1%
Net Profit YoY
-557.1%
EPS (diluted)
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
RHLD
RHLD
Q4 25
$62.1M
$117.7M
Q3 25
$52.3M
$120.9M
Q2 25
$45.6M
$119.6M
Q1 25
$41.5M
$103.9M
Q4 24
$57.5M
Q3 24
$51.5M
Q2 24
$46.6M
Q1 24
$44.9M
Net Profit
CTKB
CTKB
RHLD
RHLD
Q4 25
$-44.1M
$-1.7M
Q3 25
$-5.5M
$-231.0K
Q2 25
$-5.6M
$-611.0K
Q1 25
$-11.4M
$-3.4M
Q4 24
$9.6M
Q3 24
$941.0K
Q2 24
$-10.4M
Q1 24
$-6.2M
Gross Margin
CTKB
CTKB
RHLD
RHLD
Q4 25
52.9%
55.7%
Q3 25
52.7%
59.0%
Q2 25
52.3%
57.5%
Q1 25
48.6%
52.5%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
Operating Margin
CTKB
CTKB
RHLD
RHLD
Q4 25
-9.0%
30.2%
Q3 25
-17.6%
34.3%
Q2 25
-23.3%
34.0%
Q1 25
-36.1%
24.7%
Q4 24
5.2%
Q3 24
-8.2%
Q2 24
-18.3%
Q1 24
-23.9%
Net Margin
CTKB
CTKB
RHLD
RHLD
Q4 25
-70.9%
-1.5%
Q3 25
-10.5%
-0.2%
Q2 25
-12.2%
-0.5%
Q1 25
-27.5%
-3.2%
Q4 24
16.8%
Q3 24
1.8%
Q2 24
-22.4%
Q1 24
-13.8%
EPS (diluted)
CTKB
CTKB
RHLD
RHLD
Q4 25
$-0.20
Q3 25
$-0.03
Q2 25
$-0.07
Q1 25
$-0.39
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$90.9M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$341.7M
$6.5M
Total Assets
$461.5M
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
RHLD
RHLD
Q4 25
$90.9M
$205.5M
Q3 25
$93.3M
$148.0M
Q2 25
$75.5M
$99.9M
Q1 25
$95.3M
$71.0M
Q4 24
$98.7M
Q3 24
$162.3M
Q2 24
$177.9M
Q1 24
$168.8M
Total Debt
CTKB
CTKB
RHLD
RHLD
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CTKB
CTKB
RHLD
RHLD
Q4 25
$341.7M
$6.5M
Q3 25
$378.6M
$10.8M
Q2 25
$377.6M
$9.6M
Q1 25
$379.6M
$8.9M
Q4 24
$395.7M
Q3 24
$385.5M
Q2 24
$389.1M
Q1 24
$392.6M
Total Assets
CTKB
CTKB
RHLD
RHLD
Q4 25
$461.5M
$333.4M
Q3 25
$494.9M
$293.2M
Q2 25
$493.3M
$253.3M
Q1 25
$482.6M
$214.3M
Q4 24
$499.5M
Q3 24
$491.2M
Q2 24
$483.7M
Q1 24
$492.1M
Debt / Equity
CTKB
CTKB
RHLD
RHLD
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
RHLD
RHLD
Operating Cash FlowLast quarter
$-771.0K
$196.1M
Free Cash FlowOCF − Capex
$-1.8M
$189.2M
FCF MarginFCF / Revenue
-2.9%
160.8%
Capex IntensityCapex / Revenue
1.6%
5.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
RHLD
RHLD
Q4 25
$-771.0K
$196.1M
Q3 25
$-3.9M
$59.6M
Q2 25
$108.0K
$48.9M
Q1 25
$-125.0K
$18.4M
Q4 24
$2.0M
Q3 24
$13.2M
Q2 24
$6.2M
Q1 24
$4.0M
Free Cash Flow
CTKB
CTKB
RHLD
RHLD
Q4 25
$-1.8M
$189.2M
Q3 25
$-4.6M
$58.6M
Q2 25
$-1.5M
$47.5M
Q1 25
$-974.0K
$17.8M
Q4 24
$1.1M
Q3 24
$12.2M
Q2 24
$5.2M
Q1 24
$3.4M
FCF Margin
CTKB
CTKB
RHLD
RHLD
Q4 25
-2.9%
160.8%
Q3 25
-8.7%
48.5%
Q2 25
-3.2%
39.7%
Q1 25
-2.3%
17.1%
Q4 24
1.9%
Q3 24
23.7%
Q2 24
11.0%
Q1 24
7.6%
Capex Intensity
CTKB
CTKB
RHLD
RHLD
Q4 25
1.6%
5.8%
Q3 25
1.3%
0.8%
Q2 25
3.5%
1.2%
Q1 25
2.0%
0.6%
Q4 24
1.6%
Q3 24
2.0%
Q2 24
2.3%
Q1 24
1.3%
Cash Conversion
CTKB
CTKB
RHLD
RHLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

RHLD
RHLD

Segment breakdown not available.

Related Comparisons